SPENCER ATKINS: Open Payments
NPI 1164143343 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,696 in 84 payments from 18 companies in 2025. Trend: 2023 $1,504 · 2024 $1,767 · 2025 $1,696
Food & beverage: $1,598Education: $98
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $265 |
| Neurocrine BioSciences, Inc. | 10 | $209 |
| Axsome Therapeutics, Inc. | 12 | $204 |
| Vanda Pharmaceuticals Inc. | 6 | $172 |
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $126 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Alkermes, Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $67 |
| Lundbeck LLC | 3 | $61 |
Products named: INGREZZA, REXULTI, FANAPT, Sunosi, CAPLYTA, AUSTEDO XR, LYBALVI, Auvelity.
Industry payments across UT — which companies pay providers there.
